Fixing Psychiatric Research At A University
By Ed Silverman,
Pharmalot
| 03. 20. 2013
[Op-Ed]
Over the past few years, University of Minnesota bioethicist Carl Elliott has explored a complicated and increasingly controversial episode over a clinical trial and a suicide. The saga has involved researchers at his own university, a major drugmaker, allegations of misconduct, a lawsuit and various investigations. But answers to questions continue to raise more questions, so he has initiated an online petition asking the Minnesota governor to probe his employer. He explains why…The University of Minnesota has turned me into an activist against it. Let me confess right away that this is not a role for which I am naturally suited. I have never staged a protest or addressed a rally. Nor have I ever marched with a sign. On the occasions when I am required to give public lectures, I sweat nervously and display an embarrassing tendency to pause in mid-sentence for uncomfortably long periods. But even I can work up a pretty good head of anger when I see cruelty or injustice, and this is especially true when the injustice is deliberately inflicted and the victim cannot...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Teddy Rosenbluth, The New York Times | 02.09.2026
Dr. Mehmet Oz has urged Americans to get vaccinated against measles, one of the strongest endorsements of the vaccine yet from a top health official in the Trump administration, which has repeatedly undermined confidence in vaccine safety.
Dr. Oz, the...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...